CLINICAL TRIALS PROFILE FOR CORLOPAM
✉ Email this page to a colleague
All Clinical Trials for CORLOPAM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00982527 ↗ | Fenoldopam in Pediatric Cardiac Surgery | Completed | Bambino Gesù Hospital and Research Institute | Phase 3 | 2009-09-01 | The purpose of this study is to determine whether fenoldopam infusion during cardiopulmonary bypass in young children with congenital heart disease is able to reduce indicators of acute kidney injury (biomarkers reduction, diuresis increase) compared to a control group. |
NCT00747331 ↗ | Fenoldopam and Splanchnic Perfusion During Cardiopulmonary Bypass | Completed | IRCCS Policlinico S. Donato | Phase 4 | 2008-09-01 | Cardiopulmonary bypass (CPB) for cardiac operations may be accompanied by different patterns of visceral underperfusion. This could result in clinical patterns of lactic acidosis but in the most severe cases there is the risk for mesenteric infarction (0.2% of the cases). Renal function as well may be impaired due to a low oxygen delivery, and acute renal failure occurs in 1-2% of cases. Fenoldopam mesilate is a selective splanchnic vasodilator when used at a dose < 0.1 mcg/kg/min. The experimental hypothesis of this randomized, controlled trial (RCT) is that the use of fenoldopam may determine a better visceral perfusion during CPB. |
NCT00621790 ↗ | Fenoldopam and Acute Renal Failure | Completed | Università Vita-Salute San Raffaele | Phase 3 | 2008-02-01 | Patients undergoing cardiac surgery could develop postoperative acute renal failure requiring renal replacement therapy. Fenoldopam, already used for patients with hypertensive emergencies, could improve renal function in critically ill patients with or at risk for acute renal failure. |
NCT01324245 ↗ | Intervention Study to Compare the Natriuretic Effects of Enalapril on Low and High Salt Diet | Completed | University of Virginia | N/A | 2002-11-01 | The kidney plays a crucial role in maintaining salt balance by two opposing physiological mechanisms: the renal dopaminergic system which enhances salt excretion and the renin-angiotensin system (RAS) which causes salt retention. Salt-sensitive hypertension occurs when this balance is altered or abnormal. We hypothesized that this balance is influenced by salt intake: therefore dietary salt affects the natriuretic response to the renal dopaminergic agonist Fenoldopam, and the Angiotensin Converting Enzyme inhibitor, Enalapril. In this trial we study normal salt balance mechanisms in salt resistant adults with normal blood pressure. |
NCT00122018 ↗ | An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery | Completed | Abbott | Phase 2 | 2002-05-01 | Patients with abnormal kidney function are at increased risk for complications following heart surgery, including worsening kidney function possibly requiring dialysis, a prolonged stay in the critical care unit and hospital, and the increased risk of death. Prior attempts at kidney protection for heart surgery patients have had mixed results. Two medicines, fenoldopam and N-acetylcysteine, have been shown to protect kidney function in other circumstances that cause kidney stress. The purpose of this study is to determine whether these medications will help to maintain the function of diseased kidneys during heart surgery. |
NCT00122018 ↗ | An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery | Completed | Linda F. Barr, M.D. | Phase 2 | 2002-05-01 | Patients with abnormal kidney function are at increased risk for complications following heart surgery, including worsening kidney function possibly requiring dialysis, a prolonged stay in the critical care unit and hospital, and the increased risk of death. Prior attempts at kidney protection for heart surgery patients have had mixed results. Two medicines, fenoldopam and N-acetylcysteine, have been shown to protect kidney function in other circumstances that cause kidney stress. The purpose of this study is to determine whether these medications will help to maintain the function of diseased kidneys during heart surgery. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CORLOPAM
Condition Name
Clinical Trial Locations for CORLOPAM
Trials by Country
Clinical Trial Progress for CORLOPAM
Clinical Trial Phase
Clinical Trial Sponsors for CORLOPAM
Sponsor Name